Ionizable Lipid Composition for Targeted Nanoparticle Self-Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing lipid nanoparticles lack efficient targeting and self-assembly capabilities for vaccine or drug delivery, particularly in enhancing binding to antibodies and peptides, and optimizing cellular uptake.
Innovation Solution
Development of an ionizable lipid with a specific structure represented by formula (I) and a preparation method involving a diamine compound and pan-lactone, esterified with a carboxylic acid to form a lipid nanoparticle composition comprising ionizable lipid, phospholipid, sterol, and polyethylene glycol lipid, which allows for enhanced binding and targeting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing lipid nanoparticles are used, then the basic vaccine delivery function is achieved, but the targeting ability and binding to antibodies/peptides is insufficient
Solution Approach 1:
The patent modifies the lipid structure at specific locations (headgroup region) by introducing ionizable groups that can bind to antibodies and peptides. This localized functional enhancement allows the lipid nanoparticle to maintain its basic delivery function while gaining improved targeting capability through specific molecular interactions at the particle surface.
Solution Approach 2:
The invention changes the chemical parameters of the lipid by incorporating ionizable groups with specific pKa values that enable pH-dependent binding to antibodies and peptides. This parameter modification allows the lipid nanoparticle to dynamically adjust its binding capability in response to physiological pH changes, enhancing both targeting and adaptability.
2Reliability
If ionizable lipid with enhanced binding capability is introduced, then targeting ability is improved, but the complexity of lipid structure and preparation increases
Solution Approach 1:
The ionizable lipid is designed as a segmented molecular structure with distinct functional regions: a hydrophobic tail region for membrane integration, a linker region for flexibility, and a headgroup region containing the ionizable antibody-binding moiety. This segmentation allows each region to perform its specific function independently, simplifying the overall design while achieving enhanced targeting capability.
3Productivity
If self-assembly capability is enhanced for better cellular uptake, then vaccine delivery efficiency is improved, but the control over nanoparticle formation becomes more difficult
Solution Approach 1:
The ionizable lipid is designed to autonomously self-assemble into nanoparticles through its intrinsic amphiphilic properties, with the ionizable headgroups spontaneously organizing to create stable structures. This self-service capability eliminates the need for complex external assembly protocols, improving cellular uptake efficiency while maintaining controllable nanoparticle formation through the lipid's inherent structural design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ionizable lipid nanoparticles demonstrate improved cellular uptake and targeting ability, suitable for vaccine or drug delivery, with a dissociation constant suitable for neutral to positively charged conditions in physiological and acidic environments.
Implementation Method 1
the ionizable lipids are also useful for the self-assembly of nanoparticles and ribonucleic acid (RNA)
Implementation Method 2
Ionizable lipids can enhance the ability of the lipid nanoparticles to bind to antibodies or peptides
Data Source
AI summary
An ionizable lipid having a structure represented by the following formula (I):wherein Y is independently selected from a group consisting of —NH—, —O—, —S—, and a single bond; X is independently selected from —NR1R2 or a nitrogen-containing heteroaryl group; L1 and L2 are each independently selected from a group consisting of a C1-C10 alkylene group, a C2-C10 alkenylene group,R1 and R2 are each independently selected from a group consisting of H, a substituted or unsubstituted C1-C10 hydrocarbyl group, a substituted or unsubstituted C1-C10 heterohydrocarbyl group, a substituted or unsubstituted C6-C20 aryl group, and a substituted or unsubstituted C1-C20 heteroaryl group; R3 is a C5-C30 alkyl group; R4 is a C5-C30 alkyl group; n is an integer selected from 1 to 10; and m and p are each independently an integer selected from 1 to 20.